XAI-Driven Skin Disease Classification: Leveraging GANs to Augment ResNet-50 Performance

Addressing data imbalance improves fairness: The study used GANs to generate synthetic training data for underrepresented skin disease categories in the HAM10000 dataset. This approach helps ensure the AI system performs equally well across all disease types rather than favoring common conditions, which is critical for equitable healthcare.

Explainability is essential for clinical trust: The researchers integrated LIME and SHAP tools to show why the model made each diagnosis prediction, confirming it focused on clinically relevant features like irregular morphology. This transparency is necessary before deploying AI in real medical settings where doctors need to understand and verify the system's reasoning.

High accuracy alone isn't sufficient: Despite achieving 92.50% overall accuracy, the authors identified that melanoma detection (F1-Score of 0.8602) needs improvement and flagged this as a priority for future work. This demonstrates responsible AI development recognizes that performance gaps in critical disease categories pose real safety risks.

Validation frameworks matter for responsible deployment: The paper emphasizes creating a "verifiable framework" combining both high performance and interpretability rather than treating these as separate concerns. This integrated approach is what enables safe real-world use in clinical decision-making.